Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114539097B reveals a mild Pd-catalyzed cyanation of sulfonium salts. This method offers reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108640917B reveals a novel Rh-catalyzed one-pot synthesis for indolo isoquinoline intermediates, offering significant supply chain and cost advantages.
Novel palladium-catalyzed carbonylation method for high-purity quinolone intermediates. Offers significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN116986969B enables high-purity fluoroallyl alcohol via photocatalysis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104193667B reveals divergent nitrogen heterocycle synthesis offering cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN117164506B reveals efficient carbonylation route. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Patent CN113307790B reveals a metal-free oxidative cyclization route for quinolyl-triazoles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116813544B reveals catalyst-free heating method for quinoline. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN110317221B reveals a novel palladium-catalyzed route to polysubstituted alkynamidines using simple alkynyl bromides and isonitriles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering safer conditions and broader substrate scope for API intermediates.
Patent CN107628964B enables mild carbonylation. Reduces cost and improves supply chain for pharma intermediates. High purity and scalable production.
Novel one-pot synthesis patent CN104478885A enables efficient production. Delivers supply chain stability and cost advantages for global pharmaceutical intermediate manufacturing partners.
Patent CN112126942B details a green electrochemical method for synthesizing tetra-substituted hydrazines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Analyzing patent CN115677674B for efficient heterocyclic compound synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering a cost-effective, scalable alternative to palladium methods for API intermediates.
Patent CN112125856A reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113773253A reveals a mild AgI-catalyzed route to fully substituted pyrazoles. Discover high-yield synthesis for cost-effective API manufacturing.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering safer conditions and broader substrate scope for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates using cheap nitro compounds.
Patent CN115160211B reveals a green one-step synthesis for isoindolinone compounds using rhodium catalysis, offering significant cost and supply chain advantages for pharmaceutical manufacturers.